AOBI — American Oriental Bioengineering Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for American Oriental Bioengineering, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2008 December 31st	2009 December 31st	R2010 December 31st	2011 December 31st	C2012 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-Q
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	68.1	91.1	94.6	52.6	7.1
Net Total Accounts Receivable
Net Total Receivables	38.1	58.6	119	99.2	50.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	132	178	245	196	95.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	124	124	132	171	171
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	529	576	610	565	446
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45.4	47	44.1	160	106
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	180	182	182	183	119
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	349	395	428	382	328
Total Liabilities & Shareholders' Equity	529	576	610	565	446
Total Common Shares Outstanding
Total Preferred Shares Outstanding